Logo image of ALGEV.PA

GEVELOT SA (ALGEV.PA) Stock Fundamental Analysis

EPA:ALGEV - FR0000033888 - Common Stock

181 EUR
0 (0%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

4

Overall ALGEV gets a fundamental rating of 4 out of 10. We evaluated ALGEV against 105 industry peers in the Machinery industry. No worries on liquidiy or solvency for ALGEV as it has an excellent financial health rating, but there are worries on the profitability. ALGEV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALGEV was profitable.
In the past year ALGEV had a positive cash flow from operations.
ALGEV had positive earnings in each of the past 5 years.
ALGEV had a positive operating cash flow in 4 of the past 5 years.
ALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

The Return On Assets of ALGEV (1.21%) is worse than 60.00% of its industry peers.
Looking at the Return On Equity, with a value of 1.52%, ALGEV is doing worse than 64.76% of the companies in the same industry.
With a Return On Invested Capital value of 0.76%, ALGEV is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for ALGEV is significantly below the industry average of 8.67%.
Industry RankSector Rank
ROA 1.21%
ROE 1.52%
ROIC 0.76%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ALGEV.PA Yearly ROA, ROE, ROICALGEV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

Looking at the Profit Margin, with a value of 2.38%, ALGEV is in line with its industry, outperforming 45.71% of the companies in the same industry.
In the last couple of years the Profit Margin of ALGEV has declined.
ALGEV's Operating Margin of 1.68% is on the low side compared to the rest of the industry. ALGEV is outperformed by 74.29% of its industry peers.
ALGEV's Operating Margin has declined in the last couple of years.
ALGEV has a better Gross Margin (63.62%) than 88.57% of its industry peers.
In the last couple of years the Gross Margin of ALGEV has remained more or less at the same level.
Industry RankSector Rank
OM 1.68%
PM (TTM) 2.38%
GM 63.62%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
ALGEV.PA Yearly Profit, Operating, Gross MarginsALGEV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

ALGEV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ALGEV has been reduced compared to 1 year ago.
Compared to 5 years ago, ALGEV has less shares outstanding
Compared to 1 year ago, ALGEV has a worse debt to assets ratio.
ALGEV.PA Yearly Shares OutstandingALGEV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
ALGEV.PA Yearly Total Debt VS Total AssetsALGEV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.70 indicates that ALGEV is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 3.70, ALGEV belongs to the best of the industry, outperforming 81.90% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that ALGEV is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.03, ALGEV belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 3.7
ROIC/WACC0.1
WACC7.66%
ALGEV.PA Yearly LT Debt VS Equity VS FCFALGEV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 5.18 indicates that ALGEV has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.18, ALGEV belongs to the best of the industry, outperforming 96.19% of the companies in the same industry.
A Quick Ratio of 3.79 indicates that ALGEV has no problem at all paying its short term obligations.
ALGEV has a Quick ratio of 3.79. This is amongst the best in the industry. ALGEV outperforms 97.14% of its industry peers.
Industry RankSector Rank
Current Ratio 5.18
Quick Ratio 3.79
ALGEV.PA Yearly Current Assets VS Current LiabilitesALGEV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

ALGEV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -75.10%.
ALGEV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.19% yearly.
Looking at the last year, ALGEV shows a decrease in Revenue. The Revenue has decreased by -8.66% in the last year.
The Revenue has been growing slightly by 5.90% on average over the past years.
EPS 1Y (TTM)-75.1%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-126.43%
Revenue 1Y (TTM)-8.66%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%-8.45%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALGEV.PA Yearly Revenue VS EstimatesALGEV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALGEV.PA Yearly EPS VS EstimatesALGEV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2 4 6 8 10

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 41.42 indicates a quite expensive valuation of ALGEV.
Compared to the rest of the industry, the Price/Earnings ratio of ALGEV indicates a slightly more expensive valuation: ALGEV is more expensive than 62.86% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ALGEV to the average of the S&P500 Index (27.06), we can say ALGEV is valued expensively.
ALGEV is valuated correctly with a Price/Forward Earnings ratio of 13.37.
ALGEV's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of ALGEV to the average of the S&P500 Index (22.69), we can say ALGEV is valued slightly cheaper.
Industry RankSector Rank
PE 41.42
Fwd PE 13.37
ALGEV.PA Price Earnings VS Forward Price EarningsALGEV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALGEV is valued a bit more expensive than 61.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.47
ALGEV.PA Per share dataALGEV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALGEV does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)11.67
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.76%, ALGEV has a reasonable but not impressive dividend return.
ALGEV's Dividend Yield is rather good when compared to the industry average which is at 2.87. ALGEV pays more dividend than 80.95% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, ALGEV has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.76%

5.2 History

The dividend of ALGEV is nicely growing with an annual growth rate of 21.15%!
Dividend Growth(5Y)21.15%
Div Incr Years4
Div Non Decr Years5
ALGEV.PA Yearly Dividends per shareALGEV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

ALGEV pays out 117.62% of its income as dividend. This is not a sustainable payout ratio.
The dividend of ALGEV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP117.62%
EPS Next 2YN/A
EPS Next 3YN/A
ALGEV.PA Yearly Income VS Free CF VS DividendALGEV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M
ALGEV.PA Dividend Payout.ALGEV.PA Dividend Payout, showing the Payout Ratio.ALGEV.PA Dividend Payout.PayoutRetained Earnings

GEVELOT SA

EPA:ALGEV (9/5/2025, 7:00:00 PM)

181

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)10-30 2025-10-30
Inst Owners1.21%
Inst Owner ChangeN/A
Ins Owners7.72%
Ins Owner ChangeN/A
Market Cap135.75M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.76%
Yearly Dividend5.17
Dividend Growth(5Y)21.15%
DP117.62%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 41.42
Fwd PE 13.37
P/S 0.98
P/FCF N/A
P/OCF 31.42
P/B 0.63
P/tB 0.64
EV/EBITDA 13.47
EPS(TTM)4.37
EY2.41%
EPS(NY)13.53
Fwd EY7.48%
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)5.76
OCFY3.18%
SpS184.19
BVpS288.75
TBVpS284.6
PEG (NY)11.67
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.21%
ROE 1.52%
ROCE 1%
ROIC 0.76%
ROICexc 0.85%
ROICexgc 0.87%
OM 1.68%
PM (TTM) 2.38%
GM 63.62%
FCFM N/A
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ROICexc(3y)3.55%
ROICexc(5y)3.63%
ROICexgc(3y)3.61%
ROICexgc(5y)3.72%
ROCE(3y)3.99%
ROCE(5y)3.37%
ROICexcg growth 3Y-45.56%
ROICexcg growth 5Y-35.96%
ROICexc growth 3Y-45.2%
ROICexc growth 5Y-34.4%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.85
Cap/Depr 107.05%
Cap/Sales 5.14%
Interest Coverage 250
Cash Conversion 48.26%
Profit Quality N/A
Current Ratio 5.18
Quick Ratio 3.79
Altman-Z 3.7
F-Score6
WACC7.66%
ROIC/WACC0.1
Cap/Depr(3y)120.29%
Cap/Depr(5y)120.78%
Cap/Sales(3y)5.31%
Cap/Sales(5y)6.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75.1%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-126.43%
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.66%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%-8.45%
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-81.83%
EBIT growth 3Y-30.96%
EBIT growth 5Y-22.68%
EBIT Next Year84.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-180.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.26%
OCF growth 3Y-10.1%
OCF growth 5Y-0.33%